JEAN-JACQUES LEFRERE, M.D.; DANIELLE GOZIN, Ph.D.; JOELLE LERABLE
This content is PDF only. Please click on the PDF icon to access.
To the editor: The prevalence of circulating anticoagulant has been reported to be high in patients with the acquired immunodeficiency syndrome (AIDS) (1, 2). The association of circulating anticoagulant with Pneumocystis carinii pneumonia has been described by some authors (1) but has not been found by others (3). We prospectively studied the prevalence of this anomaly in asymptomatic persons seropositive for the human immunodeficiency virus (HIV).
Twenty-three nonhemophiliac, asymptomatic HIV-seropositive persons detected through systematic screening of blood donations were enrolled. Mean duration of the follow-up was 17 months (range, 12 to 18); 13 subjects had three semestrial controls,
LEFRERE J, GOZIN D, LERABLE J. Circulating Anticoagulant in Asymptomatic Persons Seropositive for Human Immunodeficiency Virus (HIV). Ann Intern Med. ;108:771. doi: 10.7326/0003-4819-108-5-771_1
Download citation file:
Published: Ann Intern Med. 1988;108(5):771.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use